Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
lotus eye hosp & inst l stock

LOTUS EYE HOSP & INST L Share Price

63.9 -0.88 (-1.35%)
Nov 21 2024 03:30 PM Healthcare NSE: LOTUSEYE

LOTUS EYE HOSP & INST L Share Price Update

As of the latest trading session, LOTUS EYE HOSP & INST L share price is currently at 63.9, which is down by -0.88 from its previous closing. Today, the stock has fluctuated between 62.45 and 67.58. Over the past year, LOTUS EYE HOSP & INST L has achieved a return of -31.87 %. In the last month alone, the return has been -9.44 %. Read More...

LOTUS EYE HOSP & INST L Performance

Day Range

Low62.45 High67.58
63.90

52 Week Range

Low 48.50 High 102.00
63.90

LOTUS EYE HOSP & INST L Share Price

16811

532998

LOTUSEYE

img img img img
No Data Available

Open Price

67.58

Prev. Close

64.79

Volume (Shares)

12641.00

Total traded value

8.07

Upper Circuit

68.02

Lower Circuit

61.55

Note: The current prices & values are delayed, Login to your account for live updates.

LOTUS EYE HOSP & INST L Fundamentals


(Standalone)

Market Cap (Cr) 132.90
PE Ratio (TTM) 94.43
Book Value / Share 28.89
Beta 0.62
ROE 4.97%
EPS (TTM) 0.69
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.10

LOTUS EYE HOSP & INST L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 12.91
Operating Expense 13.07
Net Profit 0.10
Net Profit Margin (%) 0.77
Earnings Per Share (EPS) 0.05
EBITDA 1.42
Effective Tax Rate (%) 9.09
Particulars JUN 2024 (Values in Cr)
Revenue 12.89
Operating Expense 12.34
Net Profit 0.62
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 0.30
EBITDA 1.98
Effective Tax Rate (%) 26.74
Particulars MAR 2024 (Values in Cr)
Revenue 10.88
Operating Expense 11.28
Net Profit 0.02
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.01
EBITDA 1.16
Effective Tax Rate (%) -200.00
Particulars DEC 2023 (Values in Cr)
Revenue 12.03
Operating Expense 11.46
Net Profit 0.66
Net Profit Margin (%) 5.48
Earnings Per Share (EPS) 0.32
EBITDA 1.92
Effective Tax Rate (%) 26.66
Particulars SEP 2023 (Values in Cr)
Revenue 12.73
Operating Expense 11.82
Net Profit 0.85
Net Profit Margin (%) 6.67
Earnings Per Share (EPS) 0.41
EBITDA 2.09
Effective Tax Rate (%) 28.57
Particulars MAR 2024 (Values in Cr)
Revenue 48.21
Operating Expense 45.51
Net Profit 2.91
Net Profit Margin (%) 6.03
Earnings Per Share (EPS) 1.40
EBITDA 7.84
Effective Tax Rate (%) 27.43
Particulars MAR 2023 (Values in Cr)
Revenue 47.04
Operating Expense 42.54
Net Profit 4.08
Net Profit Margin (%) 8.67
Earnings Per Share (EPS) 1.96
EBITDA 8.73
Effective Tax Rate (%) 27.78
Particulars MAR 2022 (Values in Cr)
Revenue 38.91
Operating Expense 35.69
Net Profit 2.98
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 1.44
EBITDA 6.72
Effective Tax Rate (%) 27.13
Particulars MAR 2021 (Values in Cr)
Revenue 32.37
Operating Expense 31.20
Net Profit 1.57
Net Profit Margin (%) 4.85
Earnings Per Share (EPS) 0.75
EBITDA 4.38
Effective Tax Rate (%) 21.10
Particulars MAR 2020 (Values in Cr)
Revenue 40.55
Operating Expense 39.30
Net Profit 1.06
Net Profit Margin (%) 2.61
Earnings Per Share (EPS) 0.51
EBITDA 4.03
Effective Tax Rate (%) 26.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.57
ROE % 4.97
ROCE % 7.06
Total Debt to Total Equity 0.02
EBITDA Margin 16.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.69
ROE % 7.27
ROCE % 10.18
Total Debt to Total Equity 0.02
EBITDA Margin 18.77
Particulars MAR 2022 (Values in Cr)
Book Value / Share 26.26
ROE % 5.55
ROCE % 7.81
Total Debt to Total Equity 0.02
EBITDA Margin 17.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.34
ROE % 3.02
ROCE % 4.01
Total Debt to Total Equity 0.01
EBITDA Margin 13.78
Particulars MAR 2020 (Values in Cr)
Book Value / Share 24.65
ROE % 2.86
ROCE % 4.59
Total Debt to Total Equity 0.01
EBITDA Margin 12.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.04
Total Assets 66.62
Total Liabilities 66.62
Total Equity 59.40
Share Outstanding 20796330
Price to Book Ratio 1.98
Return on Assets (%) 4.37
Return on Capital (%) 4.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.41
Total Assets 63.18
Total Liabilities 63.18
Total Equity 57.57
Share Outstanding 20796330
Price to Book Ratio 2.10
Return on Assets (%) 6.45
Return on Capital (%) 7.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.84
Total Assets 61.60
Total Liabilities 61.60
Total Equity 54.60
Share Outstanding 20796330
Price to Book Ratio 2.03
Return on Assets (%) 4.84
Return on Capital (%) 5.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.91
Total Assets 59.22
Total Liabilities 59.22
Total Equity 52.69
Share Outstanding 20796330
Price to Book Ratio 1.65
Return on Assets (%) 2.64
Return on Capital (%) 2.98
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.01
Total Assets 58.10
Total Liabilities 58.10
Total Equity 51.25
Share Outstanding 20796330
Price to Book Ratio 0.95
Return on Assets (%) 1.83
Return on Capital (%) 2.08
Particulars MAR 2024 (Values in Cr)
Net Income 4.00
Cash from Operations 6.68
Cash from Investing -4.63
Cash from Financing -3.40
Net change in Cash -2.35
Free Cash Flow 12.25
Particulars MAR 2023 (Values in Cr)
Net Income 5.65
Cash from Operations 5.79
Cash from Investing -2.19
Cash from Financing -1.70
Net change in Cash 0.48
Free Cash Flow 8.89
Particulars MAR 2022 (Values in Cr)
Net Income 4.10
Cash from Operations 5.25
Cash from Investing -3.93
Cash from Financing -1.57
Net change in Cash -1.09
Free Cash Flow 9.94
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 3.02
Cash from Investing 0.48
Cash from Financing -0.31
Net change in Cash 2.89
Free Cash Flow 3.50
Particulars MAR 2020 (Values in Cr)
Net Income 2.14
Cash from Operations 5.24
Cash from Investing -0.68
Cash from Financing 0.13
Net change in Cash 4.42
Free Cash Flow 7.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6681.60 81.21 12.82 96071.16 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 53.50 0.00 3.36 100.27 44.00 / 107.94
SHREE PACETRONIX LTD. 121.20 19.52 3.24 43.62 114.95 / 316.85
TRANSGENE BIOTEK LTD. 6.73 0.00 4.70 50.99 5.79 / 12.46
VIMTA LABS LIMITED 743.25 30.92 4.81 1651.00 390.60 / 804.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6681.60 85.55 11.72 96071.16 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 38.70 0.00 -20.73 28.91 28.42 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5335.90 28.94 5.99 5837.47 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 65.20
  • 26 Days 68.00
  • 10 Days 66.20
  • 50 Days 71.10
  • 12 Days 66.70
  • 100 Days 69.40
  • 20 Days 67.50
  • 200 Days 74.40
65.70
PIVOT
First Resistance 66.99
Second Resistance 69.20
Third Resistance 70.49
First Support 63.49
Second Support 62.20
Third Support 59.99
RSI 42.25
MACD -1.30
Commodity Channel Index (CCI) -77.89
ADX 46.16
Williams % R -82.87

Over 1 Month

down

-9.44

Over 3 Months

down

-14.23

Over 6 Months

down

6.73

Over 1 Year

down

-31.87

Over 3 Years

down

11.97

Over 5 Years

down

24.11

LOTUS EYE HOSP & INST L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

LOTUS EYE HOSP & INST L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
59.96
Promoter Holdings
40.03
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sangeetha S Shareholding of Promoter and Promoter Group 3918039.0 18.84
Kavetha Sundaramoorthy Shareholding of Promoter and Promoter Group 3905356.0 18.78
Kovai Purani Finance Private Limited Public Shareholding 1318684.0 6.34
Vramath Investment Consultancy Pvt Ltd Public Shareholding 1006584.0 4.84
Rajiv Choudhary Public Shareholding 855523.0 4.11
Sangeeta Choudhary Public Shareholding 815000.0 3.92
Kaliannagounder Sundaramoorthy Shareholding of Promoter and Promoter Group 501837.0 2.41
Mahendran Devika Public Shareholding 409522.0 1.97
Kalpesh Harakhchand Gala Public Shareholding 310000.0 1.49
K S Ramalingam Public Shareholding 298360.0 1.43
V. Saroja Shareholding of Promoter and Promoter Group 100.0 0.0
S.a. Karuppasamy Shareholding of Promoter and Promoter Group 100.0 0.0
S Rajkumar Shareholding of Promoter and Promoter Group 0.0 0.0

LOTUS EYE HOSP & INST L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-18 0.5 Final 2023-09-18 Equity shares 2022-09-08 0.5 Final 2022-09-10 Equity shares 2021-09-08 0.5 Final 2021-09-11 Equity shares 2018-09-14 0.5 Final 2018-09-18 Equity shares 2017-08-02 0.5 Final 2017-08-04 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About LOTUS EYE HOSP & INST L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by LOTUS EYE HOSP & INST L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Lotus Eye Hospital & Institute Ltd?

Answer Field

The share price of Lotus Eye Hospital & Institute Ltd for NSE is ₹ 63.9 and for BSE is ₹ 65.3.

What is the Market Cap of Lotus Eye Hospital & Institute Ltd?

Answer Field

The market cap of Lotus Eye Hospital & Institute Ltd for NSE is ₹ 1,32.90 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Lotus Eye Hospital & Institute Ltd?

Answer Field

The 52 Week High and Low of Lotus Eye Hospital & Institute Ltd for NSE is ₹ 102.00 and ₹ 48.50 and for BSE is ₹ 102.00 and ₹ 44.10.

How to Buy Lotus Eye Hospital & Institute Ltd share?

Answer Field

You can trade in Lotus Eye Hospital & Institute Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Lotus Eye Hospital & Institute Ltd?

Answer Field

The 1 year returns on the stock has been -31.87%.

What is the Current Share Price of Lotus Eye Hospital & Institute Ltd?

Answer Field

Lotus Eye Hospital & Institute Ltd share price is for NSE ₹ 63.9 & for BSE ₹ 65.3 as on Nov 21 2024 03:30 PM.

What is the Market Cap of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

The market cap of Lotus Eye Hospital & Institute Ltd for NSE ₹ 1,32.90 & for BSE ₹ 0.0 as on Nov 21 2024 03:30 PM.

What is the P/E Ratio of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

As on Nov 21 2024 03:30 PM the price-to-earnings (PE) ratio for Lotus Eye Hospital & Institute Ltd share is 94.43.

What is the PB ratio of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

As on Nov 21 2024 03:30 PM, the price-to-book (PB) ratio for Lotus Eye Hospital & Institute Ltd share is 28.89.

How to Buy Lotus Eye Hospital & Institute Ltd Share?

Answer Field

You can trade in Lotus Eye Hospital & Institute Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lotus Eye Hospital & Institute Ltd Share on Bajaj Broking App?

Answer Field

To buy Lotus Eye Hospital & Institute Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lotus Eye Hospital & Institute Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader